A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.

Mario Javier Pineda,Jeanne M. Schilder,Emily K. Hill,Deanna Gek Koon Teoh,Emma L. Barber,Sharon E. Robertson,Anna E. Strohl,Jiahui Xu,Masha Kocherginsky,Daniela Matei

A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.

2020

Mario Javier Pineda
Jeanne M. Schilder
Emily K. Hill
Deanna Gek Koon Teoh
Emma L. Barber
Sharon E. Robertson
Anna E. Strohl
Jiahui Xu
Masha Kocherginsky
Daniela Matei

6022Background: There are limited chemotherapeutic options for patients (pts) with advanced or recurrent endometrial cancer (EC). Reported objective response rates (ORR) for first-line doxorubicin/...

Keywords:

Paclitaxel
Carboplatin
Pembrolizumab
Recurrent Endometrial Cancer
Cancer research
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations